Trials / Completed
CompletedNCT00348335
Efficacy of Topical Cyclosporin for Ocular Rosacea
Efficacy of Topical Cyclosporin 0.05% for the Treatment of Ocular Rosacea
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Ophthalmic Consultants of Long Island · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
Detailed description
The study is designed to compare the efficacy of topical cyclosporin (Restasis) with that of Refresh Endura for the treatment of the signs and symptoms of ocular rosacea in patients presently controlled on topical corticosteroids
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclosporine 0.05% | |
| DRUG | Ocular lubricant |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2007-09-01
- Completion
- 2007-09-01
- First posted
- 2006-07-04
- Last updated
- 2011-07-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00348335. Inclusion in this directory is not an endorsement.